AI assistant
Sending…
SOLIGENIX, INC. — Director's Dealing 2021
May 18, 2021
35119_dirs_2021-05-18_3e2ed970-56f8-448c-a92d-66094fe7920c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SOLIGENIX, INC. (SNGX)
CIK: 0000812796
Period of Report: 2021-05-14
Reporting Person: ZELDIS JEROME B (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-14 | Common Stock | P | 3000 | $0.888 | Acquired | 25917 | Direct |
| 2021-05-14 | Common Stock | S | 3000 | $0.9002 | Disposed | 22917 | Direct |
Footnotes
F1: The Reporting Person's sale of 3,000 shares of the Issuer's common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, with the purchase of 3,000 shares of the Issuer's common stock reported herein. The Reporting Person has voluntarily agreed to disgorge to the Issuer the full amount of the resulting statutory "profit" calculated pursuant to Section 16(b) of the Securities Exchange Act of 1934, as amended.
More from SOLIGENIX, INC.
Regulatory Filings
2026
May 28
Capital/Financing Update
2026
May 28
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Interim / Quarterly Report
2026
May 8
Capital/Financing Update
2026
May 8
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Apr 28
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3